Alps Advisors Inc Aurinia Pharmaceuticals Inc. Transaction History

Alps Advisors Inc

  • $17.2 Billion
  • Q2 2025

A detailed history of Alps Advisors Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 72,863 shares of AUPH stock, worth $862,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,863
Previous 98,822 26.27%
Holding current value
$862,697
Previous $794,000 22.29%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$7.2 - $8.64 $186,904 - $224,285
-25,959 Reduced 26.27%
72,863 $617,000
Q1 2025

Apr 30, 2025
SELL
$7.55 - $8.77 $127,972 - $148,651
-16,950 Reduced 14.64%
98,822 $794,000
Q4 2024

Feb 13, 2025
BUY
$6.75 - $10.44 $47,513 - $73,487
7,039 Added 6.47%
115,772 $1.04 Million
Q3 2024

Nov 12, 2024
SELL
$5.32 - $7.33 $15,039 - $20,721
-2,827 Reduced 2.53%
108,733 $797,000
Q2 2024

Aug 13, 2024
BUY
$4.81 - $5.78 $45,954 - $55,222
9,554 Added 9.37%
111,560 $637,000
Q1 2024

May 14, 2024
BUY
$4.93 - $9.31 $7,306 - $13,797
1,482 Added 1.47%
102,006 $511,000
Q4 2023

Feb 14, 2024
SELL
$7.13 - $9.49 $37,696 - $50,173
-5,287 Reduced 5.0%
100,524 $903,000
Q3 2023

Nov 14, 2023
BUY
$7.77 - $12.27 $5,229 - $8,257
673 Added 0.64%
105,811 $822,000
Q2 2023

Aug 14, 2023
BUY
$8.96 - $11.69 $100,405 - $130,998
11,206 Added 11.93%
105,138 $1.02 Million
Q1 2023

May 10, 2023
SELL
$5.94 - $11.27 $15,176 - $28,794
-2,555 Reduced 2.65%
93,932 $1.03 Million
Q4 2022

Feb 14, 2023
BUY
$4.11 - $8.14 $78,057 - $154,594
18,992 Added 24.51%
96,487 $416,000
Q3 2022

Nov 14, 2022
SELL
$6.66 - $12.39 $43,889 - $81,650
-6,590 Reduced 7.84%
77,495 $583,000
Q2 2022

Aug 11, 2022
BUY
$8.95 - $12.8 $752,560 - $1.08 Million
84,085 New
84,085 $845,000
Q4 2021

Feb 09, 2022
SELL
$17.78 - $33.08 $2.79 Million - $5.2 Million
-157,076 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$10.93 - $23.55 $115,038 - $247,863
-10,525 Reduced 6.28%
157,076 $3.48 Million
Q2 2021

Aug 11, 2021
SELL
$10.0 - $14.52 $611,760 - $888,275
-61,176 Reduced 26.74%
167,601 $2.17 Million
Q1 2021

May 07, 2021
BUY
$12.3 - $18.73 $11,832 - $18,018
962 Added 0.42%
228,777 $2.97 Million
Q4 2020

Feb 03, 2021
BUY
$12.94 - $16.05 $859,940 - $1.07 Million
66,456 Added 41.19%
227,815 $3.15 Million
Q3 2020

Nov 04, 2020
BUY
$13.19 - $16.66 $103,079 - $130,197
7,815 Added 5.09%
161,359 $2.38 Million
Q2 2020

Aug 05, 2020
BUY
$14.12 - $18.33 $2.17 Million - $2.81 Million
153,544 New
153,544 $2.5 Million
Q4 2017

Feb 05, 2018
SELL
$4.53 - $7.09 $372,198 - $582,535
-82,163 Closed
0 $0
Q3 2017

Nov 03, 2017
BUY
$5.71 - $6.9 $469,150 - $566,924
82,163
82,163 $515,000

Others Institutions Holding AUPH

# of Institutions
250
Shares Held
62.6M
Call Options Held
1.03M
Put Options Held
666K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.68B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email